These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27624652)

  • 21. Bexarotene reduces blood-brain barrier permeability in cerebral ischemia-reperfusion injured rats.
    Xu L; Cao F; Xu F; He B; Dong Z
    PLoS One; 2015; 10(4):e0122744. PubMed ID: 25844636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-817MA, a neuroprotective agent, attenuates the motor and cognitive impairments associated with neuronal degeneration in P301L tau transgenic mice.
    Fukushima T; Nakamura A; Iwakami N; Nakada Y; Hattori H; Hoki S; Yamaguchi H; Nakagawa M; Terashima N; Narita H
    Biochem Biophys Res Commun; 2011 Apr; 407(4):730-4. PubMed ID: 21439944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective effects of bexarotene against amyloid-β25-35-induced dysfunction in hippocampal neurons through the insulin signaling pathway.
    Dai W; Yang J; Chen T; Yang Z
    Neurodegener Dis; 2014; 14(2):77-84. PubMed ID: 24802415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tau deposition drives neuropathological, inflammatory and behavioral abnormalities independently of neuronal loss in a novel mouse model.
    Cook C; Kang SS; Carlomagno Y; Lin WL; Yue M; Kurti A; Shinohara M; Jansen-West K; Perkerson E; Castanedes-Casey M; Rousseau L; Phillips V; Bu G; Dickson DW; Petrucelli L; Fryer JD
    Hum Mol Genet; 2015 Nov; 24(21):6198-212. PubMed ID: 26276810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Stress c-Jun N-terminal Kinase Signaling Pathway Activation Correlates with Synaptic Pathology and Presents A Sex Bias in P301L Mouse Model of Tauopathy.
    Buccarello L; Musi CA; Turati A; Borsello T
    Neuroscience; 2018 Nov; 393():196-205. PubMed ID: 30315879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased O-GlcNAcylation reduces pathological tau without affecting its normal phosphorylation in a mouse model of tauopathy.
    Graham DL; Gray AJ; Joyce JA; Yu D; O'Moore J; Carlson GA; Shearman MS; Dellovade TL; Hering H
    Neuropharmacology; 2014 Apr; 79():307-13. PubMed ID: 24326295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy.
    Hansen HH; Barkholt P; Fabricius K; Jelsing J; Terwel D; Pyke C; Knudsen LB; Vrang N
    Brain Res; 2016 Mar; 1634():158-170. PubMed ID: 26746341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection against Experimental Stroke by Ganglioside GM1 Is Associated with the Inhibition of Autophagy.
    Li L; Tian J; Long MK; Chen Y; Lu J; Zhou C; Wang T
    PLoS One; 2016; 11(1):e0144219. PubMed ID: 26751695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain-derived neurotrophic factor protects against tau-related neurodegeneration of Alzheimer's disease.
    Jiao SS; Shen LL; Zhu C; Bu XL; Liu YH; Liu CH; Yao XQ; Zhang LL; Zhou HD; Walker DG; Tan J; Götz J; Zhou XF; Wang YJ
    Transl Psychiatry; 2016 Oct; 6(10):e907. PubMed ID: 27701410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RNA-sequencing reveals transcriptional up-regulation of Trem2 in response to bexarotene treatment.
    Lefterov I; Schug J; Mounier A; Nam KN; Fitz NF; Koldamova R
    Neurobiol Dis; 2015 Oct; 82():132-140. PubMed ID: 26071899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies.
    Wagner J; Krauss S; Shi S; Ryazanov S; Steffen J; Miklitz C; Leonov A; Kleinknecht A; Göricke B; Weishaupt JH; Weckbecker D; Reiner AM; Zinth W; Levin J; Ehninger D; Remy S; Kretzschmar HA; Griesinger C; Giese A; Fuhrmann M
    Acta Neuropathol; 2015 Nov; 130(5):619-31. PubMed ID: 26439832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy.
    Popelová A; Pražienková V; Neprašová B; Kasperová BJ; Hrubá L; Holubová M; Zemenová J; Blum D; Železná B; Galas MC; Kuneš J; Maletínská L
    J Alzheimers Dis; 2018; 62(4):1725-1736. PubMed ID: 29614684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Terminal hypothermic Tau.P301L mice have increased Tau phosphorylation independently of glycogen synthase kinase 3α/β.
    Maurin H; Lechat B; Borghgraef P; Devijver H; Jaworski T; Van Leuven F
    Eur J Neurosci; 2014 Jul; 40(2):2442-53. PubMed ID: 24754737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The CNS in inbred transgenic models of 4-repeat Tauopathy develops consistent tau seeding capacity yet focal and diverse patterns of protein deposition.
    Eskandari-Sedighi G; Daude N; Gapeshina H; Sanders DW; Kamali-Jamil R; Yang J; Shi B; Wille H; Ghetti B; Diamond MI; Janus C; Westaway D
    Mol Neurodegener; 2017 Oct; 12(1):72. PubMed ID: 28978354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of oxidized and reduced forms of methylthioninium in two transgenic mouse tauopathy models.
    Melis V; Magbagbeolu M; Rickard JE; Horsley D; Davidson K; Harrington KA; Goatman K; Goatman EA; Deiana S; Close SP; Zabke C; Stamer K; Dietze S; Schwab K; Storey JM; Harrington CR; Wischik CM; Theuring F; Riedel G
    Behav Pharmacol; 2015 Jun; 26(4):353-68. PubMed ID: 25769090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pre-ischemia melatonin treatment alleviated acute neuronal injury after ischemic stroke by inhibiting endoplasmic reticulum stress-dependent autophagy via PERK and IRE1 signalings.
    Feng D; Wang B; Wang L; Abraham N; Tao K; Huang L; Shi W; Dong Y; Qu Y
    J Pineal Res; 2017 Apr; 62(3):. PubMed ID: 28178380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bexarotene Promotes Cholesterol Efflux and Restricts Apical-to-Basolateral Transport of Amyloid-β Peptides in an In Vitro Model of the Human Blood-Brain Barrier.
    Kuntz M; Candela P; Saint-Pol J; Lamartinière Y; Boucau MC; Sevin E; Fenart L; Gosselet F
    J Alzheimers Dis; 2015; 48(3):849-62. PubMed ID: 26402114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphorylation of protein Tau by GSK3β prolongs survival of bigenic Tau.P301L×GSK3β mice by delaying brainstem tauopathy.
    Crespo-Biel N; Theunis C; Borghgraef P; Lechat B; Devijver H; Maurin H; Van Leuven F
    Neurobiol Dis; 2014 Jul; 67():119-32. PubMed ID: 24704314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model.
    Zhang B; Yao Y; Cornec AS; Oukoloff K; James MJ; Koivula P; Trojanowski JQ; Smith AB; Lee VM; Ballatore C; Brunden KR
    Mol Neurodegener; 2018 Nov; 13(1):59. PubMed ID: 30404654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.